Global Cord Blood Corporation Share Price Deutsche Boerse AG
Equities
6CB
KYG393421030
Healthcare Facilities & Services
Sales 2021 | 115.96Cr 16Cr 15Cr 1.33TCr | Sales 2022 | 124.33Cr 17Cr 16Cr 1.43TCr | Capitalization | 296.79Cr 41Cr 38Cr 3.42TCr |
---|---|---|---|---|---|
Net income 2021 | 51Cr 7.02Cr 6.49Cr 584.55Cr | Net income 2022 | 50Cr 6.92Cr 6.4Cr 576.49Cr | EV / Sales 2021 | -2.13 x |
Net cash position 2021 | 607.4Cr 84Cr 78Cr 6.99TCr | Net cash position 2022 | 666.08Cr 92Cr 85Cr 7.66TCr | EV / Sales 2022 | -2.97 x |
P/E ratio 2021 |
7.1
x | P/E ratio 2022 |
5.93
x | Employees | 1,202 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 38.41% |
Managers | Title | Age | Since |
---|---|---|---|
Ting Zheng
CEO | Chief Executive Officer | 52 | 01/09/01 |
Bing Chuen Chen
DFI | Director of Finance/CFO | 48 | 01/09/01 |
Xin Xu
CTO | Chief Tech/Sci/R&D Officer | 70 | 01/04/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer J. Weng
BRD | Director/Board Member | 56 | 01/09/01 |
Ting Zheng
CEO | Chief Executive Officer | 52 | 01/09/01 |
Director/Board Member | 56 | 01/09/01 |
1st Jan change | Capi. | |
---|---|---|
+20.12% | 8.52TCr | |
-4.23% | 2.58TCr | |
+2.81% | 1.77TCr | |
-15.31% | 1.62TCr | |
+0.22% | 1.54TCr | |
+75.22% | 1.35TCr | |
+74.08% | 1.29TCr | |
+40.02% | 1.29TCr | |
+2.74% | 1.22TCr |